Page 88 - Ram Prasad Sahu/undefined

Cadila Healthcare shines on better prospects, earnings

The company had underperformed the broader markets over last year due to weak growth in the US market

Sobha Developers: Sales slip on approval delays, FY14 guidance at risk

Analysts believe that the company will be able to achieve about four million square feet of sales for FY14

No near-term upside for Maruti Suzuki

Given the stock's 45% rise since September, some analysts do not rule out price correction in the short term

No near term trigger for Maruti Suzuki

Stock is up over 40% since September on market share gains, higher margins and expectations of a sales rebound

Dish TV: Strategy on track, gains priced in

The Dish TV stock has gained 50% since the start of September on the back of plans by the DTH operator to improve its margins

Tesco move could lead to re-rating of Trent

First investment in a supermarket by a foreign chain is a win-win for both companies

Worst over, expect Bharti to outperform

Easing regulatory concerns and faster growth will benefit both Idea and Bharti, with latter being preferred on account of valuations

SpiceJet and Tigerair to tap each other's network with interline pact

Expects to wipe out accumulated losses by roping in potential investors; rebound to profits in a year

Street concerns at Torrent-Elder deal

Analysts are divided on the deal valuations. Some say Torrent could have bargained harder, as Sanofi, among others, passed it over

Acquisition deal: Few benefits for Elder, margin concerns for Torrent

Deal adds to Torrent's debt, marketmen to keep an eye on its ability to scale up

Torrent-Elder deal: Higher leverage, margin concerns for Street

The Rs 2,000 cr deal will increase Torrent's current debt of Rs 913 crore and debt to equity at 0.4 as of Sep 2013

Sun TV: Valuations turn attractive

Stock price correction a good opportunity to buy given steep discount to Zee Entertainment and strong medium term prospects

Pharma MNCs: Pricing, regulatory clarity a boost

Higher volumes could see these companies reverse their underperformance cycle vis-à-vis the industry

Bharti Infratel: Awaiting stronger 3G signals

The deal with Reliance Jio is likely to improve its tower utilization and increase its rentals per tower

Bharti Infratel: Awaiting stronger 3G signals

Stock up 5% in trade on higher dividend expectation, rentals

Strong pill in medium doses

While large-cap pharma has been a star performer, select few mid-caps could outperform

Pharma: Strong pill in medium doses

While large cap pharma companies have been the star performers thus far, select companies down the pecking order could outperform going ahead

Exide: Running on low power

Given the pressure on volumes, the company will find it difficult to maintain its pricing premium, margins and market share

Low competition positive for Dr Reddy's

A large limited competition portfolio and supply issues at Wockhardt will boost Dr Reddy's revenues from the US market

Dr Reddy's: Strong US portfolio to aid revenue growth

A large limited competition product portfolio in the US market and supply issues at Wockhardt will help the company improve its US sales and profitability